Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

February-10-06

Australia Moves Closer to Allowing Mifepristone Access

The Australian Senate passed a measure this week that will increase women’s access to mifepristone. The bill takes the regulation of mifepristone (also known as RU-486) away from the Minister of Health, giving regulatory power to the Therapeutic Goods Administration, a non-elected government agency. While under the oversight of the Minister of Health, currently abortion-opponent Tony Abbott, the drug was effectively banned.

The Australian Medical Association recommended allowing mifepristone prescriptions, and placing decisions about the drug in the hands of the Therapeutic Goods Administration. Senator Lyn Allison, leader of the Australian Democrats party, said, "It is galling listening to the men, and it is mostly men, who have such contempt for women who terminate unwanted pregnancies,” reports Reuters. In the course of debate, Allison challenged that attitude by telling parliament about her own experience, saying “an estimated one in three women have had an abortion and I am one of those.”

Feminist Majority Foundation Medical Director Beth Jordan, MD, testified before Community Affairs Committee of the Australian Senate in support of the legalization of mifepristone in Australia. “Decades of research and long-term surveillance data worldwide on mifepristone document that it is an effective medication that has been safely used by millions of women,” said Dr. Jordan. “Medication abortion should be made widely and easily available to the women and men of Australia for safe, effective and early abortion as well as for compassionate use purposes for patients with health-threatening conditions.”

The House of Representatives has not yet voted on the measure, though it is expected to vote next week, and the measure is considered likely to pass, reports AFP.

DONATE to support the Feminist Majority Foundation’s Campaign for Women’s Health and Mifepristone

LEARN MORE about mifepristone’s potential to treat life-threatening women’s reproductive cancers

Media Resources: AFP 2/9/06; Kaiser 2/9/06; Reuters 2/9/06; Testimony of Beth Jordan 1/16/06


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

7/28/2014 Study: Texas Laws Have Significantly Reduced Access to Abortion - The Texas Policy Evaluation Project (TxPEP) released a study in the medical journal Contraception finding that access to abortion has been significantly reduced since the state enacted it omnibus anti-abortion law HB2. The study, released last week, details the striking impact that HB2 has had on abortion access in Texas. . . .
 
7/28/2014 Wisconsin Will Not Enforce Contraceptive Coverage Law If Employers Raise Religious Objections - Citing the recent United States Supreme Court ruling in Burwell v. . . .
 
7/25/2014 Senate Foreign Relations Committee Passes Disabilities Treaty - By a vote of 12 to 6, the Senate Foreign Relations Committee agreed to recommend ratification of the United Nations Convention on the Rights of Persons with Disabilities to the full US Senate. "One hundred forty six nations and the European Union have ratified the Disabilities Treaty, but it will require American leadership to ensure the treaty's protections become a reality," said Senator Bob Menendez (D-NJ), Chair of the Foreign Relations Committee. . . .